X4 Pharmaceuticals shares jump 10.07% intraday as golden cross technical pattern signals bullish breakout.

X4 Pharmaceuticals (XFOR) surged 10.07% intraday after its 50-day moving average crossed above the 200-day moving average, forming a bullish "golden cross" technical pattern. This crossover, signaling potential upward momentum, coincided with a recent 8.4% rise in the stock over four weeks and a Zacks Rank of #3 (Hold), suggesting a breakout potential. Analysts highlighted that earnings estimates for the current quarter have improved, with four upward revisions in 60 days, reinforcing the bullish trend. While valuation metrics like the 10.6x price-to-sales ratio remain below the biotech industry median (12.4x), the short-term revenue growth and technical signals appear to have driven immediate investor optimism, overshadowing concerns about uneven medium-term revenue performance. The golden cross and earnings upgrades directly align with the intraday rally, making them the primary catalysts for the sharp price increase.